Mouse and other murine models are indispensable tools in translational clinical research to study disease mechanisms and therapeutic interventions.
Designed specifically for these experiments, the NULISA Mouse Panel encompasses 120 proteins selected for their involvement in inflammation, neurodegeneration, and oncogenesis.
Enabling multiplexed analysis of cytokines, chemokines, and immune- and neurology-related proteins, such as pTau217, using less than 25 μL of sample input from mouse and murine models.
The NULISA Mouse Panel offers the most comprehensive coverage of protein markers in mouse models supporting preclinical and translational research, including for:
This Nature Communications paper demonstrates the exceptional performance of the NUcleic acid Linked Immuno-Sandwich Assay (NULISA™) in detecting biologically important low-abundance biomarkers.
As both a Certified Service Provider for NULISA panels and the only multi-omics partner with a molecular-clinical database in which to confirm findings from these assays, Sapient uniquely offers:
"*" indicates required fields
